Additional file 1: Table S1. Characteristics of used studies and consortia. Table S2. Single nucleotide polymorphisms (SNPs) associated with circulating antioxidants, minerals and vitamins. Table S3. Associations of antioxidants, minerals and vitamins with MetS in sensitivity analyses. Table S4. Associations of antioxidants, minerals and vitamins with WC in sensitivity analyses. Table S5. Associations of antioxidants, minerals and vitamins with hypertension in sensitivity analyses. Table S6. Associations of antioxidants, minerals and vitamins with HDL-C in sensitivity analyses. Table S7. Associations of antioxidants, minerals and vitamins with FBG in sensitivity analyses. Table S8. Associations of antioxidants, minerals and vitamins with TG...
Results for the regression model of the unstratified population with the five MetS. Table S2âS4. R...
Additional file 1: Fig. S1.. Subgroup analyses for the association of TyG index and uncontrolled hyp...
Vital status according to administered medication in coronary artery disease patients (n = 577). Tab...
Table S5. Logistic regression for components of MetS (impaired fasting blood glucose, risky waist ci...
Table S1. Selected SNP genotyping distribution of WC separately by gender using a dominant genetic m...
Figure S1. The relationship between sdLDL-c/LDL-c ratio and prevalence of MetS. Table S1. Logistic r...
Multivariable-adjusted odds ratio of metabolic syndrome and its components according to serum 25(OH)...
Table S1. Association of genetically predicted 0.1-mmol/L increase in serum magnesium with coronary ...
Excessive oxidative stress can contribute to metabolic syndrome (MetS), and antioxidants can protect...
Table S1. Clinical characteristics of cases and controls (stage I). Table S2. Clinical characteristi...
Additional file 1: Table S1. Genetic variants used as instrumental variables for mitochondrial DNA c...
Table S1. Plasma concentration of vitamin D binding protein at its different genotypes. Table S2. Me...
Table S1. HyperGEN family structure. Table S2. Baseline characteristics of REGARDS study participant...
Additional file 1: Supplement Figure 1. Scatterplot for the significant Mendelian randomization (MR)...
Table S1. Characteristics of participants included in the vitamin D and methylation substudy (Sister...
Results for the regression model of the unstratified population with the five MetS. Table S2âS4. R...
Additional file 1: Fig. S1.. Subgroup analyses for the association of TyG index and uncontrolled hyp...
Vital status according to administered medication in coronary artery disease patients (n = 577). Tab...
Table S5. Logistic regression for components of MetS (impaired fasting blood glucose, risky waist ci...
Table S1. Selected SNP genotyping distribution of WC separately by gender using a dominant genetic m...
Figure S1. The relationship between sdLDL-c/LDL-c ratio and prevalence of MetS. Table S1. Logistic r...
Multivariable-adjusted odds ratio of metabolic syndrome and its components according to serum 25(OH)...
Table S1. Association of genetically predicted 0.1-mmol/L increase in serum magnesium with coronary ...
Excessive oxidative stress can contribute to metabolic syndrome (MetS), and antioxidants can protect...
Table S1. Clinical characteristics of cases and controls (stage I). Table S2. Clinical characteristi...
Additional file 1: Table S1. Genetic variants used as instrumental variables for mitochondrial DNA c...
Table S1. Plasma concentration of vitamin D binding protein at its different genotypes. Table S2. Me...
Table S1. HyperGEN family structure. Table S2. Baseline characteristics of REGARDS study participant...
Additional file 1: Supplement Figure 1. Scatterplot for the significant Mendelian randomization (MR)...
Table S1. Characteristics of participants included in the vitamin D and methylation substudy (Sister...
Results for the regression model of the unstratified population with the five MetS. Table S2âS4. R...
Additional file 1: Fig. S1.. Subgroup analyses for the association of TyG index and uncontrolled hyp...
Vital status according to administered medication in coronary artery disease patients (n = 577). Tab...